BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37354248)

  • 1. Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis.
    Turla A; Laganà M; Cremaschi V; Zamparini M; De Maria L; Consoli F; Abate A; Tamburello M; Alberti A; Sigala S; Grisanti S; Fontanella MM; Cosentini D; Berruti A
    J Endocrinol Invest; 2024 Jan; 47(1):223-234. PubMed ID: 37354248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study.
    Baur J; Büntemeyer TO; Megerle F; Deutschbein T; Spitzweg C; Quinkler M; Nawroth P; Kroiss M; Germer CT; Fassnacht M; Steger U;
    BMC Cancer; 2017 Aug; 17(1):522. PubMed ID: 28778197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation.
    Veltri A; Basile D; Calandri M; Bertaggia C; Volante M; Porpiglia F; Calabrese A; Puglisi S; Basile V; Terzolo M
    Eur Radiol; 2020 Dec; 30(12):6958-6964. PubMed ID: 32621242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: a retrospective study.
    Zhang F; Liu Z; Liang J; Liu S; Wu K; Zhang F; Zhou C; Lu Y; Zhu Y; Wang X
    BMC Cancer; 2021 Aug; 21(1):961. PubMed ID: 34445989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors.
    Bilimoria KY; Shen WT; Elaraj D; Bentrem DJ; Winchester DJ; Kebebew E; Sturgeon C
    Cancer; 2008 Dec; 113(11):3130-6. PubMed ID: 18973179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Mitotane and Locoregional Treatments in Low-volume Metastatic Adrenocortical Carcinoma.
    Boilève A; Mathy E; Roux C; Faron M; Hadoux J; Tselikas L; Al Ghuzlan A; Hescot S; Leboulleux S; de Baere T; Lamartina L; Deschamps F; Baudin E
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4698-e4707. PubMed ID: 34143888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
    Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of adrenocortical carcinoma. Predictive value of the D11 monoclonal antibody.
    Tartour E; Caillou B; Tenenbaum F; Schröder S; Luciani S; Talbot M; Schlumberger M
    Cancer; 1993 Dec; 72(11):3296-303. PubMed ID: 8242556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
    Werner RA; Kroiss M; Nakajo M; Mügge DO; Hahner S; Fassnacht M; Schirbel A; Bluemel C; Higuchi T; Papp L; Zsótér N; Buck AK; Bundschuh RA; Lapa C
    Endocrine; 2016 Sep; 53(3):791-800. PubMed ID: 27138903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry.
    Michalkiewicz E; Sandrini R; Figueiredo B; Miranda EC; Caran E; Oliveira-Filho AG; Marques R; Pianovski MA; Lacerda L; Cristofani LM; Jenkins J; Rodriguez-Galindo C; Ribeiro RC
    J Clin Oncol; 2004 Mar; 22(5):838-45. PubMed ID: 14990639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to radiation therapy in adrenocortical carcinoma.
    Hermsen IG; Groenen YE; Dercksen MW; Theuws J; Haak HR
    J Endocrinol Invest; 2010 Nov; 33(10):712-4. PubMed ID: 20220294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes following surgical management of adrenocortical carcinoma: A single-center experience.
    Turco M; Huguet J; Territo A; Fontana M; Rodriguez Faba O; Palou J; Breda A
    Arch Esp Urol; 2021 Oct; 74(8):782-789. PubMed ID: 34605409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operative management for recurrent and metastatic adrenocortical carcinoma.
    Datrice NM; Langan RC; Ripley RT; Kemp CD; Steinberg SM; Wood BJ; Libutti SK; Fojo T; Schrump DS; Avital I
    J Surg Oncol; 2012 Jun; 105(7):709-13. PubMed ID: 22189845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy.
    Grisanti S; Cosentini D; Laganà M; Morandi A; Lazzari B; Ferrari L; Volta AD; Ambrosini R; Ferrari VD; Sigala S; Berruti A
    Front Endocrinol (Lausanne); 2021; 12():624102. PubMed ID: 33716976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric adrenocortical carcinoma: clinical features and application of neoadjuvant chemotherapy.
    Lin Y; Yang S; Yang W; Cheng H; Chang X; Zhu Z; Feng J; Han J; Ren Q; Chang S; Liu S; Yu T; Hou B; Li P; Meng D; Zhang X; Qin H; Wang H
    Eur J Med Res; 2023 Oct; 28(1):411. PubMed ID: 37814272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach.
    Donatini G; Caiazzo R; Do Cao C; Aubert S; Zerrweck C; El-Kathib Z; Gauthier T; Leteurtre E; Wemeau JL; Vantyghem MC; Carnaille B; Pattou F
    Ann Surg Oncol; 2014 Jan; 21(1):284-91. PubMed ID: 24046101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
    Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
    BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric adrenal cortical carcinoma: brain metastases and relationship to NF-1, case reports and review of the literature.
    Wagner AS; Fleitz JM; Kleinschmidt-Demasters BK
    J Neurooncol; 2005 Nov; 75(2):127-33. PubMed ID: 16132517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma.
    Landwehr LS; Altieri B; Schreiner J; Sbiera I; Weigand I; Kroiss M; Fassnacht M; Sbiera S
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32474412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study.
    Simon G; Pattou F; Mirallié E; Lifante JC; Nominé C; Arnault V; de Calan L; Caillard C; Carnaille B; Brunaud L; Laplace N; Caiazzo R; Blanchard C
    Surgery; 2017 Jan; 161(1):249-256. PubMed ID: 27855966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.